Trexquant Investment LP raised its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 160.4% during the 4th quarter, Holdings Channel reports. The fund owned 205,415 shares of the medical equipment provider’s stock after acquiring an additional 126,527 shares during the period. Trexquant Investment LP’s holdings in Boston Scientific were worth $11,875,000 as of […]
Trexquant Investment LP lifted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 160.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 205,415 shares of the medical equipment provider’s stock after purchasing an additional 126,527 shares during the quarter. Trexquant […]
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker
Panagora Asset Management Inc. increased its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 4.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 61,679 shares of the medical equipment provider’s stock after acquiring an additional 2,535 shares during the quarter. Panagora Asset Management Inc.’s holdings in Boston Scientific were worth $3,566,000 at […]
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the.